Professional Documents
Culture Documents
Obstetrics
V1
1. Ex
2. A
3. Cx
4. Ex
V2
1. E
2. C
3. C
V3
1. D
2. D
3. E
V4
1. C
2. E
3. D
14. Benign disorders of the Upper Genital Tract 73%
a. Congenital Mullerian anomalies
b. Uterine Leiomyoma
c. Endometrial polyps
d. Ovarian cysts
V1
1. C
2. D
3. Ax
4. A
V2
1. C
2. E
3. A
4. B
V3
1. Dx
2. B
3. Dx
4. D
V4
1. B
2. D
3. A x
15. Endometriosis and Adenomyosis 75%
a. Endometriosis
b. Adenomyosis
V1
1. E x
2. D
3. E
V2
1. D x
2. A x
3. B
V3
1. C
2. D
3. B
V4
1. E
2. E
3. D
16. Infections of the Lower Female Reproductive Tract -75%
a. General
i. When a patient presents with STIs, assume coinfection and test accordingly
b. Urinary Tract Infections
c. The External anogenital region
i. Herpes
1. Dx associated with multinucleated giant cells and inflammation
a. Virus can be isolated from primary and recurrent infections,
though culture must be taken early in the course. Cultures
specific but not sensitive; have a 10-20% false negative rate
d. Ulcerated lesions
i. Syphilis
1. Non-specific treponemal tests VDRL and RPR
2. Specific treponemal tests FTA-ABS and TPPA
e. Nonulcerative lesions
f. Vaginal Infections
i. Trichomoniasis
1. Yellow-green discharge and associated with strawberry cervix
g. Infections of the cervix
17. Upper Female Reproductive Tract and Systemic Infections - 87.5%
a. The upper female reproductive tract
i. PID
1. any combination of endometritis, salpingitis, tubo-ovarian abscess, and
pelvic peritonitis
2. caused primarily by N. gonorrhoeae and C. trachomatis
3. Treated with cefoxitin or cefotetan + doxy
a. Low threshold for treatment as infertility is a complication
18. Pelvic Organ Prolapse -89%
a. Pelvic Organ Prolapse
V1
1. A
2. D
3. C
V2
4. A
5. B
V3
6. E
7. D
V4
8. B x
9. D
19. Urinary Incontinence 86.6%
a. Urinary incontinence
b. Stress Incontinence
c. Urgency incontinence
d. Overflow Incontinence
e. Bypass Incontinence
f. Functional Incontinence
V1
1. C
2. A
3. B
4. D
V2
1. C
2. D
3. C
V3
1. Ex
2. C
3. Dx
4. C
V4
1. A
2. C
3. C
4. C
20. Puberty, the Menstrual Cycle, and Menopause - 83%
a. Puberty
b. The menstrual cycle
c. Perimenopause
d. Menopause and postmenopause
i. Osteoporosis
1. Happens naturally after the age of 50, as bone resorption outpaces bone
deposition
2. Biggest risk factor for osteoporosis is positive family history
21. Amenorrhea -62.5%
a. Primary Amenorrhea
b. Secondary Amenorrhea
V1.
1. B
2. C
3. Cx
4. Dx
V2
1. C
2. A
3. A x
V3
1. C
2. Dx
3. Bx
4. Cx
V4
1. D
2. B
3. C
4. A
5. B
22. Abnormalities of the Menstrual Cycle -66%
a. Dysmenorrhea
b. Premenstrual Syndrome and Premenstrual Dysphoric Disorder
c. Abnormal Uterine Bleeding
d. Dysfunctional Uterine Bleeding
e. Postmenopausal bleeding
V1
1. C
2. E x
3. C
V2
1. A
2. B
3. E
V3
1. C
2. E x
3. D x
V4
1. C x
2. A
3. E x
23. Hirsutism and Virilism 81.25%
a. Normal Androgen Synthesis
b. Adrenal Disorders
c. Functional Ovarian Disorders
d. Drugs and Exogenous hormones
V1
1. A
2. B
3. C
4. C
V2
1. D
2. A
3. E
4. D
5. E
V3
1. E x
2. C
3. A x
V4
1. A
2. B
3. D
4. Ax
24. Contraception and sterilization 83%
a. General
i. The most effective contraception methods, with pregnancy rates <1%, include
depo provera, sterilization (male and female), and long acting reversible
contraception such as IUD, nexplanon
b. Natural Methods
c. Barrier Methods and Spermicides
d. Intrauterine devices
e. Hormonal Contraceptive methods
f. Emergency Contraception
g. Surgical Sterilization
V1
1. E
2. C
3. E
V2
1. A
2. D
3. C
V3
1. D
2. A
3. E
V4
1. E
2. E x
3. A x
25. Elective Termination of Pregnancy - 87%
a. First Trimester Options
b. Second Trimester Options
26. Infertility and Assisted Reproductive Techniques 100%
a. Female Factor Infertility
b. Male Factor Infertility
c. Unexplained Infertility
d. Assisted Reproductive Technologies
V1
1. B
2. D
3. C
V2
1. C
2. B
3. E
27. Neoplastic Diseases of the Vulva and Vagina -66%
a. Preinvasive neoplastic disease of the vulva
b. Cancer of the vulva
c. Preinvasive neoplastic disease of the vagina
d. Cancer of the Vagina
V1
1. E
2. A x
3. C
V2
1. D x
2. A
3. C
V3
1. E
2. D
3. B
V4
1. A x
2. A x
3. C
28. Cervical Neoplasia and Cervical Cancer 64%
a. Cervical Intraepithelial Neoplasia
i. Abnormal Pap smear management
1. Normal pap, high risk HPV positive repeat both in 1 year, or screen for
HPV 16/18. If either is positive, then go to colposcopy
2. ASCUS
a. high risk HPV negative or undetermined continue regular
screening
b. high risk HPV positive colposcopy with cervical biopsies
3. ASC-H colposcopy with biopsies
4. LSIL colposcopy with biopsies
5. HSIL colposcopy with biopsies
6. SCC colposcopy with biopsies, HPV screen, cold knife conization
7. AGC colposcopy with biopsies, EMB
ii. Cervical intraepithelial neoplasia management
1. CIN I pap smear q6mo x 1y OR HPV screen in 1 y
a. If persistent x2y, LEEP
2. CIN II LEEP
a. If young, pap and colpo q6mo x 2y
3. CIN III - LEEP
b. Cervical Cancer
29. Endometrial Cancer 63.6%
a. Pathogenesis
b. Epidemiology
c. Risk Factors
d. Clinical Manifestations
e. Diagnostic Evaluation
f. Treatment
g. Follow up
V1
1. Bx
2. D
3. E
4. C
V2
1. C x
2. C
3. D x
V3
1. A x
2. A
V4
1. D
2. A
30. Ovarian and Fallopian Tube Tumors 75%
a. Tumors of the Ovaries
b. Epithelial Tumors
c. Germ Cell Tumors
d. Sex Cord-Stromal Tumors
e. Cancer of the Fallopian Tubes
V1
1. D x
2. C x
3. A
V2
1. E
2. C
3. D
V3
1. A
2. C
3. C x
V4
1. D
2. C
3. E
31. Gestational Trophoblastic Disease 77%
a. Benign Gestational Trophoblastic Disease
b. Complete Molar pregnancy
i. Do CXR as first step once molar pregnancy has been confirmed, as lungs are
most common site of metastatic disease
c. Partial Molar Pregnancy
d. Malignant Gestational trophoblastic disease
e. Persistent/Invasive moles
f. Choriocarcinoma
g. Placental site trophoblastic tumors
32. Benign Breast Disease and Breast Cancer 83%
a. Anatomy
b. Physiology
c. Evaluation of the Breast
d. Benign Breast Disease
V1.
1. A
2. A
3. B x
V2
1. B
2. C
3. C
V3
1. D
2. E
3. B
V4
1. D x
2. A
3. D